Down syndrome and thyroid dysfunction: Should nutritional support be the first-line treatment?

Medical Hypotheses

Volumn 69, Issue 4, 2007, Pages 809-815

  Thiel, R ^a   Fowkes, Steven Wm ^a  

^a Center for Natural Health Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE; LEVOTHYROXINE SODIUM; SELENIUM; THYROXINE; TYROSINE; ZINC;

ARTICLE; CONGENITAL HYPOTHYROIDISM; DOWN SYNDROME; DYRK1A GENE; GENE; GENE OVEREXPRESSION; HUMAN; HYPOTHYROIDISM; MOTHER; NUTRITIONAL SUPPORT; PHYSICIAN; PRENATAL PERIOD; PRIORITY JOURNAL; RISK; SUPPLEMENTATION; THYROID DISEASE; THYROID FUNCTION; THYROID GLAND; TRISOMY 21;

DOWN SYNDROME; FEMALE; HUMANS; HYPOTHYROIDISM; MALE; MODELS, BIOLOGICAL; NUTRITIONAL SUPPORT; SELENIUM; THYROID GLAND; TYROSINE; ZINC;

BOVINAE;

EID: 34547830892     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2007.01.068     Document Type: Article

References (65)

1. In: Beers M.K., and Berkow R. (Eds). The Merck manual. 17th ed. (1999), Merck Research Laboratories, Whitehouse Station (NJ)
2. van Trotsenburg A.S., Kempers M.J., Endert E., Tijssen J.G., de Vijlder J.J., and Vulsma T. Trisomy 21 causes persistent congenital hypothyroidism presumably of thyroidal origin. Thyroid 16 7 (2006) 671-680
3. Kanavin O.J., Aaseth J., and Birketvedt G.S. Thyroid hypofunction in Down's syndrome. Is it related to oxidative stress?. Biol Trace Elem Res 78 (2000) 35-42
4. Van Dyke D.C., van Duyne S., Lowe O., and Heide F. Alternative and controversial therapies. Clinical perspectives in the management of Down syndrome (1990), Springer-Verlag, NY 208-216
5. Toldeo C., Alembik Y., Aguirre J.A., and Stoll C. Growth curves of children with Down syndrome. Ann Genet 42 2 (1999) 81-90 6
6. van Trotsenburg A.S., Vulsma T., van Rozenburg-Marres S.L., van Baar A.L., Ridder J.C., Heymans H.S., et al. The effect of thyroxine treatment started in the neonatal period on development and growth of two-year-old Down syndrome children: a randomized clinical trial. J Clin Endocrinol Metab 90 6 (2005) 3304-3311
7. In: Murray L. (Ed). Physician's desk reference. 60th ed. (2006), Thompson PDR, Montvale (NJ)
8. Guyton A.C., and Hall J.E. Textbook of medical physiology. 9th ed. (1996), W.B. Saunders, PA
9. Dunn J.T. Iodine. Modern nutrition in health and disease. 10th ed. (2006), Lippincott Williams & Wilkins, PA 300-311
10. Kosinska A., Syrenicz A., Kosinski B., Garanty-Bogacka B., Syrenicz M., and Gromniak E. Osteoporosis in thyroid diseases. Endokrynol Pol 56 2 (2005) 185-193
11. Langdahl B.L. Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy?. J Bone Min Res 12 1 (1997) 78-88
12. Fowler P.B., McIvor J., Sykes L., and Macrae K.D. The effect of long-term thyroxine on bone mineral density and serum cholesterol. J Roy Coll Phys Lond 30 6 (1996) 527-532
13. Versendaal D.A. Contact reflex analysis and applied trophology. 18th ed. (1990), D.A. Versandall, Holland (MI)
14. Wu S.Y., Green W.L., Huang W.S., Hays M.T., and Chopra I.J. Alternate pathways of thyroid hormone metabolism. Thyroid 15 8 (2005) 943-958
15. Ensminger A.H., Ensminger M.E., Konlande J.E., and Robson J.R.K. Food & nutrition encyclopedia. 2nd ed. (1993), CRC Press, New York
16. Aquaron R., Delange F., Marchal P., Lognone V., and Ninane L. Bioavailability of seaweed iodine in human beings. Cell Mol Biol (Noisy-le-grand) 48 5 (2002) 563-569
17. Hetzel B.S., and Clugston G.A. Iodine. Modern nutrition in health and disease. 9th ed. (1999), Williams & Wilkins, Baltimore, MD p. 253-64
18. In: Hendlor S.S., and Rorvik D. (Eds). PDR for nutritional supplements (2001), Medical Economics, Montvale (NJ)
19. van Trotsenburg A.S., Vulsma T., van Santen H.M., Cheung W., and de Vijlder J.J. Lower neonatal screening thyroxine concentrations in down syndrome newborns. J Clin Endocrinol Metab 88 4, Apr (2003) 1512-1515
20. Shaposhnikov A.M., Khal'chitskii S.E., and Shvarts E.I. Disorders of phenylalanine and tyrosine metabolism in Down's syndrome. Vopr Med Khim 25 1 (1979) 15-19
21. In: Shils M.E., Olson J.A., Shike M., and Ross A.C. (Eds). Modern nutrition in health and disease. 9th ed. (1999), Williams & Wilkins, Baltimore, MD
22. Kim EJ, Sung JY, Lee HJ, Rhim H, Hasegawa M, Iwatsubo T, et al. Dyrk1A phosphorylates alpha-synuclein and enhances intracellular inclusion formation. J Biol Chem. 2006(September 7) [E-published ahead of print].
23. Galceran J., de Graaf K., Tejedor F.J., and Becker W. The MNB/DYRK1A protein kinase: genetic and biochemical properties. J Neural Transm Suppl 67 (2003) 139-148
24. Kim D., Won J., Shin D.W., Kang J., Kim Y.J., Choi S.Y., et al. Regulation of Dyrk1A kinase activity by 14-3-3. Biochem Biophys Res Commun 323 2 (2004) 499-504
25. Kadrobova J., Madaric A., Sustrova M., and Ginter E. Changed serum element profile in Down's syndrome. Biol Trace Elem Res 54 3 (1996) 201-206
26. Monteiro C.P., Varela A., Pinto M., Neves J., Felisberto G.M., Vaz C., et al. Effects of an aerobic training program on magnesium, trace elements and antioxidant systems in Down syndrome population. Magnes Res 10 1 (1997) 65-71
27. El-Bayoumy K., Richie Jr. J.P., Boyiri T., Komninou D., Prokopczyk B., Trushin N., et al. Influence of selenium-enriched yeast supplementation on biomarkers of oxidative damage and hormone status in healthy adult males: a clinical pilot study. Cancer Epidemiol Biomarkers Prev 11 (2002) 1459-1465
28. Thiel R.J., and Fowkes S.W. Can cognitive deterioration associated with Down syndrome be reduced?. Med Hypotheses 64 3 (2005) 524-532
29. Burk R., and Levander O. Selenium. Modern nutrition in health and disease. 10th ed. (2006), Lippincott Williams & Wilkins, PA p. 312-25
30. Purice M., Maximillan C., Dumitru I., and Ioan D. Zinc and copper in plasma and erythrocytes of Down's syndrome children. Endocrinologie 26 2 (1988) 113-117
31. Stehbens W.E. Oxidative stress, toxic hepatitis, and antioxidants with particular emphasis on zinc. Exp Mol Pathol 75 3 (2003) 265-276
32. Sherman A.R. Zinc, copper and iron nurtiture and immunity. J Nutr 122 (1992) 604-609
33. Cunnane S. Zinc: clinical and biological significance (1988), CRC Press, Boca Raton
34. Bucci I., Napolitano G., Giuliani C., Lio S., Minnucci A., Di Giacomo F., et al. Zinc sulfate supplementation improves thyroid function in hypozincemic Down children. Biol Trace Elem Res 67 3 (1999) 257-268
35. Harrower H. Practical organotherapy. 3rd ed. (1921), W.B. Conkey Co., Hammond (Indiana) p. 31-6
36. Warner F.J. Nutrition and Down syndrome. Presentation at the Third Annual Convention of the California State Buena Park (2001), Naturopathic Medical Association February 11
37. Thiel R. Growth effects of the Warner protocol for children with Down syndrome. J Orthomolec Med 17 1 (2002) 42-49
38. Gardner M. Intestinal assimilation of intact peptides and protein from the diet - a neglected field?. Cambridge Philosophical Society, Biological Reviews 59 (1984) 289-331
39. Popov I.M., et al. Cell therapy. J Int Acad Prevent Med 3 (1977) 74-82
40. Burns D. Accumulating scientific evidence supports glandular therapy. Digest Chiropr Econ (1987) 74-79
41. Schwartz E.F. Glandular therapy. Am Chiropr January/February (1983) 14-18
42. Neumann C. Serious nutrition: incorporating clinically effective nutrition into your practice (2005), Source Graphics, Kelowna (BC)
43. Howell E. Enzyme nutrition (1985), Avery Publishing Group, Wayne (NJ) p. 11-29
44. Green S. A critique of the rationale for cancer treatment with coffee enemas and diet. JAMA 268 22 (1992) 3224-3227
45. Shamberger R.C., Hendron W.H., and Leictner A.M. Long-term nutritional and metabolic consequences of pancreaticoduodenectomy in children. Surgery 115 3 (1994) 382-388
46. Fiocchi A., Borella E., Riva E., Arensi D., Travaglini P., Cazzola P., et al. A double-blind clinical trial for the evaluation of the therapeutical effectiveness of a calf thymus derivative (Thymomodulin) in children with recurrent respiratory infections. Thymus 8 6 (1986) 331-339
47. Thiel R. Might disorders of calcium cause or contribute to myoclonic seizures?. Med Hypotheses 66 5 (2006) 969-974
48. Schulof R.S., et al. Phase I/II trial of thymosin fraction 5 and thymosin alpha one on HTLV-III seropositive subjects. J Biol Resp Modif 5 (1986) 429-443
49. Balch J.F., and Balch P.A. Prescription for a nutritional healing (1997), Avery Publishing, Garden City Park (NY)
50. Lee R., and Hanson W. Protomorphology: the Principles of cell auto-regulation (1947), Lee Foundation for Nutritional Research, Milwaukee
51. Hulsey M.G., and Martin R.J. The role of animals in nutritional research. Nutr Today 28 5 (1993) 1993
52. McCarren M. Animals in research: researchers use animals to learn more about human diabetes. Diabetes Forecast 46 8 (1993) 26
53. California Institute of Technology. Large genome comparison reveals details of genomic evolution. Cancer Weekly, February 10, 1992;6:3.
54. Boretti F.S., Sieber-Ruckstuhl N.S., Willi B., Lutz H., Hofmann-Lehmann R., and Reusch C.E. Comparison of the biological activity of recombinant human thyroid-stimulating hormone with bovine thyroid-stimulating hormone and evaluation of recombinant human thyroid-stimulating hormone in healthy dogs of different breeds. Am J Vet Res 67 7 (2006) 1169-1172
55. Beef, variety meats and by-products, brain, raw. USDA national nutrient database for standard reference, release 19; 2006.
56. DeCava J.A. Glandular supplements. Nutr News Views 1 3 (1997) 1-10
57. Nuttal. Blood immunity and blood relationship (1904), Cambridge University Press, London as cited in
58. Lee R., and Hanson W. Protomorphology: the principles of cell auto-regulation (1947), Lee Foundation for Nutritional Research, Milwaukee
59. Turkel H., and Nusbaum I. Medical treatment of Down syndrome and genetic diseases. 4th ed. (1985), Ubiotica, Southfield (MI)
60. Rimland B. Vitamin/mineral supplementation for Down syndrome. Lancet 2 (1983) 1255
61. Bumbalo T.S., Morelewicz H.V., and Berens D.L. Treatment of Down's syndrome with the "U" series of drugs. JAMA 187 (1964) 361
62. Harrell R.F., Capp R.H., Davis D.R., Peerless, and Ravitz L.R. Can nutritional supplements help mentally retarded children?. Proc Natl Acad Sci 78 (1981) 574-578
63. Pruess J.B., Fewell R.R., and Bennett F.C. Vitamin therapy and children with Down syndrome: a review of the research. Except Child 55 (1989) 336-341
64. Thiel R. Nutritional interventions for the thyroid. ANMA Monit 4 1 (2000) 6-14
65. Clarke N., and Kabadi U.M. Optimizing treatment of hypothyroidism. Treat Endocrinol 3 4 (2004) 217-221